Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Pfizer Inc.
Stock Watch: How To Avoid Blockbuster Loss Of Exclusivity Bringing Your Company Down
What is the difference between companies with franchises that rise and then fall into obscurity, and those that keep on rising even after loss of exclusivity?
ASCO 2023 – Trop2 Could Validate Merck’s Savvy Deal With Kelun
In Trop2 Merck & Co. might have got itself an ADC at least as good as Gilead and Astra/Daiichi’s leaders, for a fraction of the price.
ASCO 2023 – A Role For Immuno-Oncology In Ovarian Cancer At Last?
AstraZeneca’s Duo-O trial suggests that excluding Brca-positive patients could be the key to Imfinzi’s apparent success in ovarian cancer.
ASCO 2023 – Pfizer Pushes Forward In Drug-Resistant Breast Cancer
While Ibrance has been bested by class rivals Pfizer is working on projects that might overcome CDK4/6 inhibitor resistance, although it is not alone.
- Other Names / Subsidiaries
- Agouron Pharmaceuticals
- Alpharma Pharmaceuticals LLC
- American Home Products
- Amplyx Pharmaceuticals, Inc.
- Anacor Pharmaceuticals, Inc.
- Array BioPharma, Inc. (ARRY)
- Arixa Pharmaceuticals, Inc. Bamboo Therapeutics, Inc.
- Bioren, Inc,
- Coley Pharmaceutical Group, Inc.
- CovX Pharmaceuticals, Inc
- C.P. Pharmaceuticals International C.V.
- Encysive Pharmaceuticals
- FoldRx Pharmaceuticals, Inc.
- Ferrosan Consumer Health
- GD Searle
- Hisun-Pfizer Pharmaceuticals Co., Ltd.
- Hospira, Inc.
- Icagen, Inc.
- Idun Pharmaceuticals, Inc.
- Javelin Pharmaceuticals, Inc.
- King Pharmaceuticals, Inc.
- Lederle Laboratories
- Mayne Pharma Limited
- Meridica Limited
- Pharmacia and Upjohn Co.
- PHT Pharma S.r.l.
- Redvax GmbH
- ReViral Ltd.
- Strato Medical Corp.
- Texas Biothechnology Corporation
- Thiakis Limited
- Vicuron Pharmaceuticals
- ViiV Healthcare
- Wyeth-Ayerst Laboratories, Inc.
- Treerly Health Co., Ltd.
- Meridian Medical Technologies Inc.
- Montreal, Inc.
- Medivation, Inc.
- Sugen LLC
- Therachon Holding AG.
- Jones Pharma Inc.
- Trillium Therapeutics Inc.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.